Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -534.72% | -246.26% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 13,753.62% | 4,620.00% |
| Change in Net Operating Assets | -- | -- | -- | -21.18% | 646.93% |
| Cash from Operations | -- | -- | -- | -118.16% | -128.06% |
| Capital Expenditure | -- | -- | -- | 53.99% | -47.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -3,725.24% | -29.32% |
| Cash from Investing | -- | -- | -- | -34.39% | -40.71% |
| Total Debt Issued | -- | -- | -- | 132.71% | -55.83% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 885.44% | 798.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 31.09% | 473.85% |
| Cash from Financing | -- | -- | -- | 124.39% | 92.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 100.27% | 106.82% |
